WallStreetZenWallStreetZen

NASDAQ: CDLX
Cardlytics Inc Stock Forecast, Predictions & Price Target

Buy CDLX*
*Your capital is at risk. Other fees apply.
OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CDLX

Based on 2 analysts offering 12 month price targets for Cardlytics Inc

Min Forecast
$2.50+57.23%
Avg Forecast
$2.75+72.96%
Max Forecast
$3.00+88.68%

Should I buy or sell CDLX stock?

Based on 2 analysts offering ratings for Cardlytics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their CDLX stock forecasts and price targets.

CDLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-08
lockedlocked$00.00+00.00%2025-03-13

1 of 1

Forecast return on equity

Is CDLX forecast to generate an efficient return?

Company
19.66%
Industry
41.7%
Market
55.96%
CDLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDLX forecast to generate an efficient return on assets?

Company
3.41%
Industry
9.88%
CDLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDLX earnings per share forecast

What is CDLX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.31
Avg 2 year Forecast
$0.24

CDLX revenue forecast

What is CDLX's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$275.2M+0.96%
CDLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDLX revenue growth forecast

How is CDLX forecast to perform vs Advertising Agencies companies and vs the US market?

Company
0.96%
Industry
-7.32%
Market
48.31%
CDLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDLX vs Advertising Agency Stocks

TickerPricePrice TargetUp/downsideConsensus
CDLX$1.59$2.75+72.96%Hold
MCHX$2.15N/AN/A
TZUP$6.97N/AN/A
INUV$4.41$2.00-54.65%Buy
ABLV$1.02N/AN/A
View Top Advertising Agency Stocks

Cardlytics Stock Forecast FAQ

Is Cardlytics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDLX) stock is to Hold CDLX stock.

Out of 2 analysts, 0 (0%) are recommending CDLX as a Strong Buy, 0 (0%) are recommending CDLX as a Buy, 2 (100%) are recommending CDLX as a Hold, 0 (0%) are recommending CDLX as a Sell, and 0 (0%) are recommending CDLX as a Strong Sell.

If you're new to stock investing, here's how to buy Cardlytics stock.

What is CDLX's earnings growth forecast for 2025-2026?

(NASDAQ: CDLX) Cardlytics's forecast annual earnings growth rate of N/A is not forecast to beat the US Advertising Agencies industry's average forecast earnings growth rate of 49.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.75%.

Cardlytics's earnings in 2025 is -$178,310,000.On average, 1 Wall Street analyst forecast CDLX's earnings for 2025 to be -$68,778,131, with the lowest CDLX earnings forecast at -$68,778,131, and the highest CDLX earnings forecast at -$68,778,131.

In 2026, CDLX is forecast to generate $12,600,574 in earnings, with the lowest earnings forecast at $12,600,574 and the highest earnings forecast at $12,600,574.

What is CDLX's revenue growth forecast for 2025-2025?

(NASDAQ: CDLX) Cardlytics's forecast annual revenue growth rate of 0.96% is forecast to beat the US Advertising Agencies industry's average forecast revenue growth rate of -7.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 48.31%.

Cardlytics's revenue in 2025 is $272,588,000.

In 2025, CDLX is forecast to generate $14,448,657,728 in revenue, with the lowest revenue forecast at $14,448,657,728 and the highest revenue forecast at $14,448,657,728.

What is CDLX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: CDLX) forecast ROA is 3.41%, which is lower than the forecast US Advertising Agencies industry average of 9.88%.

What is CDLX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDLX price target, the average CDLX price target is $2.75, with the highest CDLX stock price forecast at $3.00 and the lowest CDLX stock price forecast at $2.50.

On average, Wall Street analysts predict that Cardlytics's share price could reach $2.75 by May 8, 2026. The average Cardlytics stock price prediction forecasts a potential upside of 72.96% from the current CDLX share price of $1.59.

What is CDLX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: CDLX) Cardlytics's current Earnings Per Share (EPS) is -$3.50. On average, analysts forecast that CDLX's EPS will be -$1.31 for 2025, with the lowest EPS forecast at -$1.31, and the highest EPS forecast at -$1.31. In 2026, CDLX's EPS is forecast to hit $0.24 (min: $0.24, max: $0.24).

What is CDLX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: CDLX) forecast ROE is 19.66%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
OSZAR »